Immunome Inc. financial data

Symbol
IMNM on Nasdaq
Location
Bothell, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790 % +5.8%
Debt-to-equity 15.38 % -8.7%
Return On Equity -87.22 % +37.6%
Return On Assets -75.6 % +36.8%
Operating Margin -2,420 % +22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91,710,277 shares +46.9%
Common Stock, Shares, Outstanding 91,706,948 shares +51.8%
Entity Public Float 642,700,000 USD +7.5%
Common Stock, Value, Issued 9,000 USD +50%
Weighted Average Number of Shares Outstanding, Basic 87,957,868 shares +46.1%
Weighted Average Number of Shares Outstanding, Diluted 87,957,868 shares +46.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9,679,000 USD -4.4%
Research and Development Expense 174,406,000 USD +91%
General and Administrative Expense 42,123,000 USD +37.9%
Operating Income (Loss) -234,222,000 USD +26.2%
Net Income (Loss) Attributable to Parent -222,743,000 USD +27.1%
Earnings Per Share, Basic -2 USD/shares +65.7%
Earnings Per Share, Diluted -2 USD/shares +65.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 272,639,000 USD +75.3%
Assets, Current 279,924,000 USD +14.7%
Property, Plant and Equipment, Net 11,563,000 USD +61.2%
Operating Lease, Right-of-Use Asset 3,125,000 USD +30.9%
Other Assets, Noncurrent 4,555,000 USD +42.4%
Assets 299,377,000 USD +16.5%
Accounts Payable, Current 6,147,000 USD +74.7%
Employee-related Liabilities, Current 7,171,000 USD +1.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 31,445,000 USD -20.4%
Contract with Customer, Liability, Noncurrent 2,208,000 USD -76.6%
Deferred Income Tax Liabilities, Net 1,033,000 USD +1.7%
Operating Lease, Liability, Noncurrent 4,013,000 USD +62.9%
Other Liabilities, Noncurrent 1,340,000 USD +20.6%
Liabilities 35,458,000 USD -15.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -658,264,000 USD -51.1%
Stockholders' Equity Attributable to Parent 263,919,000 USD +22.8%
Liabilities and Equity 299,377,000 USD +16.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53,055,000 USD -3.7%
Net Cash Provided by (Used in) Financing Activities 162,228,000 USD -26.1%
Net Cash Provided by (Used in) Investing Activities 5,089,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 91,706,948 shares +51.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 114,262,000 USD -33.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 272,849,000 USD +75.3%
Deferred Tax Assets, Valuation Allowance 106,720,000 USD +1.7%
Deferred Tax Assets, Gross 107,753,000 USD +1.7%
Operating Lease, Liability 4,013,000 USD +47.5%
Payments to Acquire Property, Plant, and Equipment 3,665,000 USD +69.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -222,813,000 USD +27%
Lessee, Operating Lease, Liability, to be Paid 17,172,000 USD +3.6%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2,330,000 USD +1.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 1,468,000 USD +66.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3,821,000 USD +5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2,383,000 USD
Deferred Tax Assets, Operating Loss Carryforwards 29,346,000 USD +28.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 56,000 USD +51.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1,616,000 USD
Additional Paid in Capital 922,174,000 USD +41.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 611,000 USD +2.9%
Deferred Tax Assets, Net of Valuation Allowance 1,033,000 USD +1.7%
Share-based Payment Arrangement, Expense 23,267,000 USD +76.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%